Urologix Sponsors Physician Education at the North Central AUA Meeting

Urologix Sponsors Physician Education at the North Central AUA Meeting

Urologix will host a hands-on workshop on Wednesday October 9th at the
upcoming North Central Section of the AUA featuring advancements in BPH
In-Office Therapy.

MINNEAPOLIS, Minn., Oct. 7, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Urologix,
Inc. (OTCQB:ULGX), the market leader for In-Office BPH Therapy, will host a
hands-on workshop at the upcoming 87th Annual Meeting of the North Central
Section of the AUA which is being held at the Ritz Carlton in Naples, Florida
from October 8-12, 2013. The hands-on workshop will feature advancements in
BPH In-Office Therapy and will take place on Wednesday, October 9th from
8:00-4:00 ET in the Plaza III conference room. The session will be led by Dr.
J. Randolf Beahrs, a board certified urologist and Director of Minimally
Invasive Office Procedures at Metro Urology in St. Paul, Minnesota. Dr. Beahrs
has extensive urologic experience and has been very involved with the North
Central Section for many years.

"Over my 30 years as a physician, I have seen many breakthroughs and new
technologies in Urology. I believe that Urologix' in-office minimally invasive
procedures are certainly another excellent breakthrough for urologists."
stated Dr. Beahrs. "There have been significant improvements in both the
technologies as well as the techniques used in these procedures. We can now
offer our patients state-of-the-art office-based solutions which result in
excellent outcomes for our patients and provide a great value for the patient,
physician, and healthcare system."

This workshop will highlight the advancements of in-office therapy over the
past ten years and provide attendees with a unique opportunity to learn about
Cooled ThermoTherapy™ and Prostiva® RF Therapy procedures from an experienced
physician. Urologists will be able to discuss procedure techniques, review the
latest clinical data, and see how the products work up close. Of special
interest, Urologix, in collaboration with Dr. Beahrs, will be introducing an
educational tool to teach a new technique for performing a periprostatic nerve
block which Dr. Beahrs has used extensively to achieve excellent patient
comfort with his in-office BPH therapy patients. To find out more about
in-office BPH therapies, visit http://www.urologix.com.

For more information or to attend the workshop, participants should stop by
the Urologix booth or contact Urologix directly at 888.229.0772 or
customerservice(at)urologix(dot)com.

BPH, also known as enlarged prostate, affects the majority of men as they age
and can create irritating symptoms which significantly impact quality of life.
This disease continues to be predominantly treated with medications; however,
research has shown that drugs are not always effective and can produce
unpleasant side effects. Cooled ThermoTherapy and Prostiva RF Therapy have
proven their results through numerous clinical studies and are recommended
treatment options within American Urology Association guidelines.

Visit http://www.urologix.com to learn more about BPH and In-Office BPH
Therapy and discover why it is as an excellent alternative to chronic
medication therapy.

About Urologix
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and
distributes minimally invasive medical products for the treatment of
obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix's
Cooled ThermoTherapy™ produces targeted microwave energy combined with a
unique cooling mechanism to protect healthy tissue and enhance patient
comfort. The Prostiva® RF Therapy System is an anatomical approach which uses
radio frequency energy to destroy the prostate tissue, reducing constriction
of the urethra, and thereby relieving BPH symptoms. Both of these therapies
provide safe, effective and lasting relief of obstruction and symptoms due to
BPH. Prostiva is a registered trademark of Medtronic, Inc., used under
license. All other trademarks are the property of Urologix.

Federal USA law restricts these devices to sale by or on the order of a
physician. For more complete information about the benefits, risks and
contraindications associated with Cooled ThermoTherapy and Prostiva RF
Therapy, please refer to http://www.urologix.com.

If you would like more information on this topic, please contact Karen Snay at
513-484-2987 or ksnay(at)urologix(dot)com. To learn more about Urologix and
its products and services, visit http://www.urologix.com.

The Urologix logo and other media assets are available at
http://www.urologix.com/clinicians/resource-library.php.

Urologix Media Contact
Karen Snay
(513) 484-2987
Ksnay(at)urologix(dot)com

Urologix Investor Relations Contact
Brian Smrdel
(763) 475-7696
Bsmrdel(at)urologix(dot)com

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit
http://www.prweb.com/releases/2013/10/prweb11201674.htm

CONTACT: Urologix, Inc.
         Karen Snay
         ksnay@urologix.com
         +1 5134842987
 
Press spacebar to pause and continue. Press esc to stop.